Biological activities of Salvia L. species

Current Issues in Pharmacy and Medical Sciences

Volumn 26, Issue 3, 2013, Pages 326-330

  Dziurzynski, Tomasz ^a   Ludwiczuk, Agnieszka ^a   Glowniak, Kazimierz ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Chemical constituents; Essential oils; Extracts; Pharmacological studies; Salvia

Indexed keywords

ABIETANE DERIVATIVE; ACETYLCHOLINE; ANTIOXIDANT; ANTIVIRUS AGENT; BETA CAROTENE; CHLOROGENIC ACID; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; CLERODANE DERIVATIVE; CRYPTOTANSHINONE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DIHYDROTANSHINONE I; DITERPENOID; ESSENTIAL OIL; ETHYL SALVIANOLATE A; FLAVONOID; LINOLEIC ACID; LITHOSPERMIC ACID; METHYL SALVIANOLATE A; POLYSACCHARIDE; ROSMARINIC ACID; SALVIA MILTIORRHIZA EXTRACT; SALVIANOLIC ACID A; SALVIANOLIC ACID B; TANSHINONE I; TANSHINONE IIA; TANSHINONE IIB; TERPENOID DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALZHEIMER DISEASE; ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIMALARIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; APOPTOSIS; ARTICLE; BIOLOGICAL ACTIVITY; CANCER CELL; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHOLINESTERASE INHIBITION; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IC 50; MACROPHAGE; MEDICINAL PLANT; NEURAL STEM CELL; NEUROPROTECTION; NONHUMAN; PHYTOCHEMISTRY; SALVIA; SALVIA MILTIORRHIZA; SALVIA OFFICINALIS; TRADITIONAL MEDICINE; VIRUS STRAIN;

EID: 84896953330     PISSN: 2084980X     EISSN: None     Source Type: Journal    
DOI: 10.12923/j.2084-980X/26.3/a.19     Document Type: Article

References (41)

1. Aruoma O.I.: Free radicals, oxidative stress and antioxidants in human health and disease. J. Am. Oil Chem. Soc., 75, 199, 1998.
2. Baj T., Ludwiczuk A, Sieniawska E. et al.: GC-MS analysis of essential oils from Salvia officinalis L.: A comparison of extraction methods of the volatile components. Acta Pol. Pharm., 70, 35, 2013.
3. Baricevic D., Sosa S., Della L.R. et al.: Topical antiinflammatory activity of Salvia officinalis L. leaves: the relevance of ursalic acid. J. Ethnopharmacol., 75, 125, 2001.
4. Bylac S., Racine P.: Inhibition of 5-lipoxygenase by essential oils and other natural fragrant extracts. Int. J. Aromather., 13, 138, 2003.
5. Esmaeili A., Rustaiyan A., Nadimi M.: Chemical composition and antibacterial activity of essential oils from leaves, stems and flowers of Salvia reuterana Boiss. grown in Iran. Nat. Prod. Res., 22, 516, 2008.
6. Foster S., Tyler V.E. :Tyler's honest herbal. A sensible guide to the use of herbs and related remedies. The Haworth Herbal Press. New York, London; p. 327, 1999.
7. Fraternale D., Giamperi L., Bucchini A. et al.: Composition and antifungal activity of essential oil of Salvia sclarea from Italy. Chem. Nat. Compd., 41, 604, 2005.
8. Gono-Bwalya A.: The chemotaxonomy and biological activity of Salvia stenophylla (Lamiaceae) and related taxa. M.Sc. Dissertation. University of the Witwatersrand, South Africa, 2003.
9. Grzegorczyk I., Matkowski A., Wysokinska H.: Antioxidant activity of extracts from in vitro cultures of Salvia officinalis L. Food Chem., 104, 536, 2007.
10. Hristova Y., Gochev V., Wanner J. et al.: Chemical composition and antifungal activity of essential oil of Salvia sclarea L. from Bulgaria against clinical isolates of Candida species. J. BioSci. Biotech., 2, 39, 2013.
11. Jeong H., Sung M., Kim Y. et al.: Anti-inflammatory activity of Salvia plebeia R. Br. leaf through heme oxygenase-1 induction in LPS-stimulated RAW264.7 macrophages. J. Korean Soc. Food Sci. Nutr., 41, 888, 2012.
12. Jirovetz L., Wlcek K., Buchbauer G. et al.: Antifungal activities of essential oils of Salvia lavandulifolia, Salvia officinalis and Salvia sclarea against various pathogenic Candida species. J. Essen. Oil Bear. Pl., 10, 430, 2007.
13. Kamatou G.P.P.: Indigenous Salvia species - an investigation of their pharmacological activities and phytochemistry. Ph.D. Thesis. University of the Witwatersrand, South Africa, 2006.
14. Kamatou G.P.P., Makunga N.P., Ramogala W.P.N., Viljoen A.M.: South African Salvia species: A review of biological activities and phytochemistry. J. Ethnopharmacol., 119, 664, 2008.
15. Kamatou G.P.P., Viljoen A.M., Gono-Bwalya A.B. et al.: The in vitro pharmacological activities and chemical investigation of three South African Salvia species. J. Ethnopharmacol., 102, 382, 2005.
16. Kamatou G.P.P., Viljoen A.M., Van Zyl R.L. et al.: The antimalarial and cytotoxic effects of solvent extracts of South African Salvia species and isolated compounds from S. radula. South African J. Bot., 74, 238, 2008.
17. Kontogianni V.G., Tomic G., Nikolic I. et al.: Phytochemical profile of Rosmarinus officinalis and Salvia officinalis extracts and correlation to their antioxidant and antiproliferative activity. Food Chem., 136, 120, 2013.
18. Liu L., Jia J., Zeng G. et al.: Studies on immunoregulatory andante-tumor activities of a polysaccharide from Salvia miltiorrhiza Bunge. Carbohydr. Polym., 92, 479, 2013.
19. Loizzo M.R., Menichini F., Tundis R. et al.: In vitro biological activity of Salvia leriifolia Benth essential oil relevant to the treatment of Alzheiner's disease. J. Oleo Sci., 58, 443, 2009.
20. Moharram F.A., Marzouk M.S., El-Shenawy S.M. et al.: Polyphenolic profile and biological activity of Salvia splendens leaves. J. Pharm. Pharmacol., 64, 1678, 2012
21. Oboh G., Henle T.: Antioxidant and inhibitory effects of aqueous extracts of Salvia officinalis leaves on pro-oxidant-induced lipid peroxidation in brain and liver in vitro. J. Med. Food, 12, 77, 2009.
22. Orhan I.E., Senol F.S., Ercetin T. et al.: Assessment of anticholinesterase and antioxidant properties of selected sage (Salvia) species with their total phenol and flavonoid contents. Ind. Crop Prod., 41, 21, 2013.
23. Park O.K., Choi J.H., Park J.H. et al.: Comparison of neuroprotective effects of five major lipophilic diterpenoids from Danshen extract against experimentally induced transient celebral ischemic damage. Fitoterapia, 83, 1666, 2012.
24. Park S.H., Kim J.L., Kang M.K. et al.: Sage weed (Salvia plebeia) extract antagonizes foam cell formation and promotes cholesterol efflux in murine macrophages. Int. J. Mol. Med., 30, 1105, 2012.
25. Peana A.T., Moretti M.D.L., Juliano C.: Chemical composition and antimicrobial action of the essential oils of Salvia desolea and S. sclarea. Planta Med., 65, 752, 1999.
26. Perry N., Court G., Bidet N. et al.: Cholinergic activities of European herbs and potential for dementia therapy. J. Geriatr. Psychiatry, 11, 1063, 1996.
27. Pierozan M.K., Pauletti G.F., Rota L. et al.: Chemical characterization and antimicrobial activity of essential oils of Salvia L. species. Ciênc. Tecnol. Aliment., 29, 764, 2009.
28. Robbers J.E., Tyler V.E.: Tyler's herbs of choice. The therapeutic use of phytomedicinals. The Haworth Herbal Press. New York, London; p. 227, 1999.
29. Savelev S.U., Okello E.J., Perry E.K.: Bytyryl- and acetylcholinesterase inhibitory activities in essential oils of Salvia species and their constituents. Phytother. Res., 18, 315, 2006.
30. Segrua-Campos M.R., Salazar-Vega I.M., Chel-Guerrero L.A. Betancur-Ancona D.A.: Biological potential of chia (Salvia hispanica L.) protein hydrolysates their incorporation into functional foods. LWT - Food Sci. Technol., 50, 723, 2013.
31. Šmidling D., Mitić-Ćulafić D., VukoviC-Gačić B. et al.: Evaluation of antiviral activity of fractionated extracts of sage Salvia officinalis L. Arch. Biol Sci., 60, 421, 2008.
32. Tepe B., Sokmen M., Akpulat H.A., Sokmen A.: Screening of the antioxidant potentials of six Salvia species from Turkey. Food Chem., 95, 200, 2006.
33. Üstün Alkan F., Esen Güirsel F., Ateş A. et al.: Protective effects of Salvia officinalis extracts against cyclophosphamide- induced genotoxicity and oxidative stress in rats. Turk. J. Vet. Anim. Sci., 36, 646, 2012.
34. Vázques-Ovando A., Rosado-Rubio G., Chel-Guerrero L., Betancur-Ancona D.: Physicochemical properties of a fibrous fraction from chia (Salvia hispanica L.). LWT - Food Sci. Technol., 42, 168, 2009.
35. 4-induced hepatic fibrosis through regulating NF-κkB/IκBα signaling. J. Ethnopharmacol., 144, 592, 2012.
36. Wolski T., Ludwiczuk A., Mardarowicz M.: Composition of essential oil and its content in leaves and gallenic preparations made of sage (Salvia officinalis L.). Annales UMCS sec. EEE, 8, 85, 2000.
37. Wu Y.B., Ni Z.Y., Shi Q.W. et al.: Constituents from Salvia species and their biological activities. Chem. Rev., 112, 5967, 2012.
38. Zeng X., Li Z., Sun L. et al.: Recovery from rat sciatic nerve injury in vivo through the use of differentiated MDSCs in vitro. Exp. Ther. Med., 5, 193, 2013.
39. Zhang N., Kang T., Xia Y. et al.: Effects of salvianolic acid B on survival, self-renewal and neuronal differentiation of bone marrow derived neural stem cells. Eur. J. Pharmacol., 697, 32, 2012.
40. Zhang Z.F., Chen H.S., Peng Z.G. et al.: A potent anti-HIV polyphenol from Salvia yunnanensis. J. Asian Nat. Prod. Res., 10, 252, 2008.
41. Zhang Z.F., Peng Z.G., Gao L. et al.: Three new derivatives of anti-HIV-1 polyphenols isolated from Salvia yunnanensis. J. Asian Nat. Prod. Res., 10, 391, 2008.